Azathioprine-Induced Acute Submandibular Sialadenitis in a Crohn’s Disease Patient
Introduction: Azathioprine (AZA) is a widely used immunosuppressive drug in inflammatory bowel disease (IBD). The occurrence of adverse effects (AEs) is a major downside in the use of this drug, leading to treatment withdrawal in a variable proportion of patients. Case Presentation: We report the ca...
Main Authors: | Joana Inês Alves da Silva, Cidalina Caetano, Isabel Pedroto |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2020-01-01
|
Series: | GE: Portuguese Journal of Gastroenterology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/505037 |
Similar Items
-
Adalimumab and azathioprine in the prevention of postoperative crohn’s disease recurrence
by: A. V. Poletova, et al.
Published: (2020-10-01) -
Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
by: Tong Li, et al.
Published: (2020-11-01) -
Sialadenitis submandibular supurativa aguda neonatal
by: Bárbara Acosta Batista, et al. -
Resected Hepatocellular Carcinoma in a Patient with Crohn’s Disease on Azathioprine
by: Valérie Heron, et al.
Published: (2016-05-01) -
Pulmonary Mycobacterium avium Infection in a Patient with Crohn's Disease under Azathioprine Treatment
by: Tomonori Hirano, et al.
Published: (2014-05-01)